干细胞治疗在单心室生理学:最新进展和未来方向

Q2 Medicine
Mohamed Abdullah MD, PhD , Samantha Kegel BS , Muthukumar Gunasekaran PhD , Progyaparamita Saha PhD , Xuebin Fu PhD , Rachana Mishra PhD , Sudhish Sharma PhD , Sunjay Kaushal MD, PhD
{"title":"干细胞治疗在单心室生理学:最新进展和未来方向","authors":"Mohamed Abdullah MD, PhD ,&nbsp;Samantha Kegel BS ,&nbsp;Muthukumar Gunasekaran PhD ,&nbsp;Progyaparamita Saha PhD ,&nbsp;Xuebin Fu PhD ,&nbsp;Rachana Mishra PhD ,&nbsp;Sudhish Sharma PhD ,&nbsp;Sunjay Kaushal MD, PhD","doi":"10.1053/j.pcsu.2021.03.003","DOIUrl":null,"url":null,"abstract":"<div><p><span><span><span>Current surgical and medical treatment options for </span>single ventricle<span> physiology conditions remain palliative. On the long term, despite treatment, the systemic ventricle has a significant risk of developing failure. There are unmet needs to develop novel treatment modalities to help ameliorate the ventricular dysfunction. Advances in the field of </span></span>stem cell therapy have been promising for the treatment of heart failure. Numerous stem cell populations have been identified. Preclinical studies in small and large animal models provide evidence for effectiveness of this treatment modality and reveal several mechanisms of action by which stem cells exert their effect. Many </span>clinical trials<span> have been designed to further investigate the therapeutic potential that stem cell therapy may hold for pediatric populations with single ventricle physiology. In this review, we discuss the stem cell types used in these populations, some preclinical studies, and the clinical trials of stem cell therapy in single ventricle patients.</span></p></div>","PeriodicalId":38774,"journal":{"name":"Pediatric Cardiac Surgery Annual","volume":"24 ","pages":"Pages 67-76"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Stem Cell Therapy in Single-Ventricle Physiology: Recent Progress and Future Directions\",\"authors\":\"Mohamed Abdullah MD, PhD ,&nbsp;Samantha Kegel BS ,&nbsp;Muthukumar Gunasekaran PhD ,&nbsp;Progyaparamita Saha PhD ,&nbsp;Xuebin Fu PhD ,&nbsp;Rachana Mishra PhD ,&nbsp;Sudhish Sharma PhD ,&nbsp;Sunjay Kaushal MD, PhD\",\"doi\":\"10.1053/j.pcsu.2021.03.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span><span><span>Current surgical and medical treatment options for </span>single ventricle<span> physiology conditions remain palliative. On the long term, despite treatment, the systemic ventricle has a significant risk of developing failure. There are unmet needs to develop novel treatment modalities to help ameliorate the ventricular dysfunction. Advances in the field of </span></span>stem cell therapy have been promising for the treatment of heart failure. Numerous stem cell populations have been identified. Preclinical studies in small and large animal models provide evidence for effectiveness of this treatment modality and reveal several mechanisms of action by which stem cells exert their effect. Many </span>clinical trials<span> have been designed to further investigate the therapeutic potential that stem cell therapy may hold for pediatric populations with single ventricle physiology. In this review, we discuss the stem cell types used in these populations, some preclinical studies, and the clinical trials of stem cell therapy in single ventricle patients.</span></p></div>\",\"PeriodicalId\":38774,\"journal\":{\"name\":\"Pediatric Cardiac Surgery Annual\",\"volume\":\"24 \",\"pages\":\"Pages 67-76\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric Cardiac Surgery Annual\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1092912621000065\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Cardiac Surgery Annual","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1092912621000065","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2

摘要

目前单心室生理条件的手术和药物治疗选择仍然是姑息性的。长期来看,尽管接受了治疗,系统性脑室仍有发生衰竭的显著风险。开发新的治疗方式来帮助改善心室功能障碍的需求尚未得到满足。干细胞治疗在治疗心力衰竭方面的进展是有希望的。已经确定了许多干细胞群。在小型和大型动物模型中的临床前研究为这种治疗方式的有效性提供了证据,并揭示了干细胞发挥其作用的几种作用机制。许多临床试验旨在进一步研究干细胞治疗可能对患有单心室生理学的儿科人群的治疗潜力。在这篇综述中,我们讨论了这些人群中使用的干细胞类型,一些临床前研究,以及干细胞治疗单脑室患者的临床试验。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Stem Cell Therapy in Single-Ventricle Physiology: Recent Progress and Future Directions

Current surgical and medical treatment options for single ventricle physiology conditions remain palliative. On the long term, despite treatment, the systemic ventricle has a significant risk of developing failure. There are unmet needs to develop novel treatment modalities to help ameliorate the ventricular dysfunction. Advances in the field of stem cell therapy have been promising for the treatment of heart failure. Numerous stem cell populations have been identified. Preclinical studies in small and large animal models provide evidence for effectiveness of this treatment modality and reveal several mechanisms of action by which stem cells exert their effect. Many clinical trials have been designed to further investigate the therapeutic potential that stem cell therapy may hold for pediatric populations with single ventricle physiology. In this review, we discuss the stem cell types used in these populations, some preclinical studies, and the clinical trials of stem cell therapy in single ventricle patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.80
自引率
0.00%
发文量
7
期刊介绍: The Pediatric Cardiac Surgery Annual is a companion to Seminars in Thoracic and Cardiovascular Surgery . Together with the Seminars, the Annual provides complete coverage of the specialty by focusing on important developments in pediatric cardiac surgery. Each annual volume has an expert guest editor who invites prominent surgeons to review the areas of greatest change in pediatric cardiac surgery during the year. Topics include 1) Complete Atrioventricular Canal; 2) New Concepts of Cardiac Anatomy and Function -- The Helical Heart; 3) Valve Reconstruction (Replacement) in Congenital Heart Disease; 4) Evolving Developments in Congenital Heart Surgery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信